Paltusotine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Paltusotine. Educational only — not medical advice.
Labeled uses
PALSONIFY is indicated for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option.
Source: FDA labeling via NIH DailyMed (set 8a6d2ce0…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.